WOOJUNG BIO Statistics

Total Valuation

WOOJUNG BIO has a market cap or net worth of KRW 32.90 billion. The enterprise value is 77.88 billion.

Market Cap	32.90B
Enterprise Value	77.88B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

WOOJUNG BIO has 16.83 million shares outstanding. The number of shares has increased by 21.65% in one year.

Current Share Class	16.83M
Shares Outstanding	16.83M
Shares Change (YoY)	+21.65%
Shares Change (QoQ)	+16.62%
Owned by Insiders (%)	33.34%
Owned by Institutions (%)	3.65%
Float	10.22M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.80
PB Ratio	1.21
P/TBV Ratio	1.25
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.67, with an EV/FCF ratio of -82.52.

EV / Earnings	-312.13
EV / Sales	1.88
EV / EBITDA	15.67
EV / EBIT	86.88
EV / FCF	-82.52

Financial Position

The company has a current ratio of 0.59, with a Debt / Equity ratio of 1.86.

Current Ratio	0.59
Quick Ratio	0.27
Debt / Equity	1.86
Debt / EBITDA	10.22
Debt / FCF	-53.88
Interest Coverage	0.29

Financial Efficiency

Return on equity (ROE) is -1.02% and return on invested capital (ROIC) is 0.74%.

Return on Equity (ROE)	-1.02%
Return on Assets (ROA)	0.60%
Return on Invested Capital (ROIC)	0.74%
Return on Capital Employed (ROCE)	1.47%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.44
Inventory Turnover	5.24

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +60.87% in the last 52 weeks. The beta is 0.99, so WOOJUNG BIO's price volatility has been similar to the market average.

Beta (5Y)	0.99
52-Week Price Change	+60.87%
50-Day Moving Average	1,646.12
200-Day Moving Average	1,805.81
Relative Strength Index (RSI)	52.50
Average Volume (20 Days)	215,091

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, WOOJUNG BIO had revenue of KRW 41.36 billion and -249.51 million in losses. Loss per share was -48.14.

Revenue	41.36B
Gross Profit	12.22B
Operating Income	899.38M
Pretax Income	-249.51M
Net Income	-249.51M
EBITDA	4.97B
EBIT	899.38M
Loss Per Share	-48.14

Full Income Statement

Balance Sheet

The company has 5.87 billion in cash and 50.85 billion in debt, giving a net cash position of -44.98 billion or -2,672.51 per share.

Cash & Cash Equivalents	5.87B
Total Debt	50.85B
Net Cash	-44.98B
Net Cash Per Share	-2,672.51
Equity (Book Value)	27.29B
Book Value Per Share	1,637.17
Working Capital	-12.63B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -459.76 million and capital expenditures -483.96 million, giving a free cash flow of -943.71 million.

Operating Cash Flow	-459.76M
Capital Expenditures	-483.96M
Free Cash Flow	-943.71M
FCF Per Share	-56.07

Full Cash Flow Statement

Margins

Gross margin is 29.55%, with operating and profit margins of 2.17% and -0.60%.

Gross Margin	29.55%
Operating Margin	2.17%
Pretax Margin	-0.60%
Profit Margin	-0.60%
EBITDA Margin	12.03%
EBIT Margin	2.17%
FCF Margin	n/a

Dividends & Yields

WOOJUNG BIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-21.65%
Shareholder Yield	n/a
Earnings Yield	-0.76%
FCF Yield	-2.87%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 30, 2019. It was a forward split with a ratio of 2.

Last Split Date	Jul 30, 2019
Split Type	Forward
Split Ratio	2

Scores

WOOJUNG BIO has an Altman Z-Score of 0.15 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.15
Piotroski F-Score	4